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Abstract
Background: It is clinically rare to find cytomegalovirus (CMV)-associated encephalomyelitis in immunocompetent
adults. Here, we present the case of an adult patient who developed acute transverse myelitis that was followed by
immune-mediated disseminated encephalomyelitis.
Case presentation: A 38-year-old man developed acute paraplegia with paresthesia below the level of the T7-8
dermatome. Both brain and spinal cord MRIs performed at admission appeared normal. Corticosteroid therapy was
initiated, with the later addition of high-dose intravenous immunoglobulins. After polymerase chain reaction analysis
indicated the presence of CMV DNA in his cerebrospinal fluid (CSF), anti-viral therapy was added. Forty days
after symptom onset, despite an initial positive response to this therapy, he developed dysarthria and truncal
ataxia. Repeated magnetic resonance imaging scans demonstrated progressively expanding lesions involving
not only the spinal cord but also the cerebral white matter, suggestive of extensive immune-mediated demyelination
involving the central nervous system (CNS), as is observed in acute disseminated encephalomyelitis (ADEM).
Conclusion: This case report underscores the importance of careful patient observation following the initial diagnosis
of a CMV-associated CNS infection, such as transverse myelitis, on the possibility that post-infectious ADEM may
appear.
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Background
Cytomegalovirus (CMV) is one of herpes viruses, and it
infects only humans. It is well known that CMV causes
central nervous system (CNS) infections in immuno-
compromised patients, such as in patients with human
immunodeficiency virus (HIV) infection or in organ
transplant recipients. By contrast, CMV infection is
typically subclinical in healthy adults. However, a few
reports have described CMV encephalomyelitis occurring
in immunocompetent patients [1–12]. Recently, we
encountered a patient with CMV-associated acute trans-
verse myelitis who developed extensive demyelinating
lesions involving the CNS, similar to those observed in
acute disseminated encephalomyelitis (ADEM), after an
interval of 40 days.
Case presentation
A 38-year-old Japanese man was admitted to our
hospital because of muscle weakness in his lower ex-
tremities. His and his family’s histories were unre-
markable. Fifteen days before admission, he had a
mild fever with fatigue. Simultaneously, itchy skin
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rashes emerge on his foot and face, particularly
around his mouth. The patient was tentatively diag-
nosed as having hand, foot, and mouth disease. Prior
to admission, his fever, fatigue, and skin rash began
to resolve, but the lower limb weakness progressively
worsened within a few days. On admission, his gen-
eral condition was unremarkable. A neurological
examination showed that he was alert and oriented.
His higher cerebral functions and cranial nerves were
intact. The patient showed spastic paraparesis, with
weakness of both lower extremities at approximately
4/5 strength. Deep tendon reflexes were brisk in all
extremities, with ankle clonus in both legs. Babinski
sings were bilaterally positive. He had paresthesia
below the level of the T7-8 dermatome. Difficulty in
micturition was noted. The patient had no sign of
meningeal irritation. The results of his laboratory
tests showed that his complete blood cell count,
chemistry, immunoglobulin levels, C-reactive protein,
erythrocyte sedimentation rate, and urinalysis were all
within reference values. In particular, alterations in
the liver function test results, suggestive of infectious
mononucleosis, were not observed. Serological tests
for syphilis, hepatitis B and C, HIV, and human
T-lymphotropic virus type 1 were negative. The test
results were also negative for anti-nuclear antibodies,
anti-double stranded DNA, and cytoplasmic and peri-
nuclear types of antineutrophil cytoplasmic antibodies,
antiphospholipid antibodies, and anti-aquaporin-4
antibody. Antibody titers were not elevated for herpes
simplex virus immunoglobulin M (IgM), varicella
zoster virus IgM, Epstein–Barr virus IgM, and CMV
IgM. CMV IgG was found elevated significantly. Add-
itionally, the tests for coxsackie A16 and enterovirus
were not significantly elevated, although we could not
perform a serodiagnosis with paired serum samples. A
malignancy survey, in which contrast-enhanced CTs
of the chest, abdomen, and pelvis were included, was
conducted in the present patient, and no cancer was
identified. Additionally, tumor markers (alpha-fetopro-
tein, CEA, CA19-9, and soluble interleukin-2 antigen)
were all within normal ranges. Examination of CSF
showed elevated white blood cells, although protein
(34 mg/dl) and glucose (57 mg/dl) levels were within
normal ranges. The CSF IgG index 0.8 was found to
be mildly elevated. The myelin basic protein (40.0 pg/ml)
levels were not increased, and there were no oligoclo-
nal IgG bands in the CSF sample. Nerve conduction
velocity studies of the peripheral nerves indicated that
they were intact. Sensory evoked potentials obtained
by tibial nerve stimulation demonstrated no reprodu-
cible waves. Both brain and spinal cord magnetic
resonance images (MRI) obtained at admission ap-
peared normal (Figs. 1, 2, and 3). Brain and spinal
cord MRI examinations with gadolinium-enhancement
were also performed, although no significant enhance-
ment was demonstrated. After admission, the patient’s
weakness and deep sensation disturbance of the lower
extremities progressively worsened. He was tentatively
diagnosed with transverse myelitis, and treatment was
started with intravenous methylprednisolone at a dose
of 1000 mg/day for 3 days, followed by oral prednis-
olone (PSL) (60 mg/day). After 7 days, the muscle
weakness in his lower extremities continued to
worsen, and we added intravenous immunoglobulin
therapy (IVIG) at a dose of 0.4 mg/kg for 5 days. Ten
days after admission, intravenous administration of
ganciclovir (600 mg/day, 19 days) was initiated
because CMV DNA was found in his CSF following
polymerase chain reaction analysis (PCR) performed
at admission. The deterioration of his symptoms
ceased, and the weakness in his lower extremities
gradually recovered. Other findings in his CSF also
improved, including the results for white blood cells
(13/mm3; all cells were lymphocytes), protein (23 mg/
dL), and glucose (62 mg/dL). The CSF samples were
also negative for CMV. However, MRI performed
again on day 26 after admission demonstrated a
spinal cord lesion of high signal intensity at cervical
levels C2–C6, suggesting that the spinal cord was
involved and may have been responsible for the para-
plegia, although his paraplegia continued to improve
with treatment (Fig. 3). Additionally, a hyperintense
signal was observed in the right frontal subcortical
white matter (Figs. 1 and 2). On day 40 after admis-
sion, the weakness and numbness of his lower
extremities again worsened, and myoclonic move-
ments appeared in his lower legs. Subsequently, a loss
of finger dexterity appeared bilaterally. In addition,
the patient developed dysarthria and truncal ataxia,
the latter of which resulted in his inability to main-
tain a sitting position. Brain MR images demonstrated
faint, irregular-shaped lesions involving cerebral white
matter with dense T2-weighted and fluid attenuated
inversion recovery (FLAIR) hyperintensities in the in-
ternal capsules, suggesting that extensive disseminated
demyelination was actively ongoing (Figs. 1 and 2).
The CSF examination results showed re-elevation of
protein (39 mg/dL), and MBP (58.9 pg/mL) was also
increased compared with results from the initial CSF
study, although both levels were within normal
ranges. The white blood cell count in the CSF did
not increase (7/mm3). We considered the possibility
that the patient had ADEM, and intravenous methyl-
prednisolone (1000 mg/day, 3 days) was administered
again, followed by IVIG (0.4 mg/kg, 5 days). After
this treatment, his neurological deterioration ceased,
but he had residual neurological sequelae. Time
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course of clinical symptoms, CSF results, treatment,
and MRI findings in the present patient are schemat-
ically shown (Fig. 4).
Discussion
The signs and symptoms in the present patient were
manifested as a biphasic clinical course. The patient’s
illness started as acute transverse myelitis, but during his
recovery, he had extensive demyelination of the cerebral
white matter. There was a time lag of about 40 days
between the two episodes. We speculated that different
pathophysiologies were responsible for this two-stage
attack: the first attack was caused by direct viral inva-
sion, and the second by an indirect, immune-
mediated mechanism.
Based on the PCR results, we concluded that the acute
transverse myelitis was caused by direct invasion of
CMV, in particular by a reinfection, because CMV IgM
but not IgG was not elevated in his CSF. However, it is
rare to detect CMV DNA in the CSF obtained from
patients with CMV-associated transverse myelitis. To
date, 12 immunocompetent patients with CMV-
associated transverse myelitis have been reported [1–12].
In only one of these patients was CMV DNA detected
by PCR in the CSF. However, none of these 12 patients
showed a two-stage attack, as in our case. Recently,
Arslan et al. [1] reviewed nine CMV myelitis case
reports and found poor prognosis in eight. Symmetrical
symptoms with moderate to severe spinal cord dysfunc-
tion [1] and rapid progression of symptoms [5] are
Fig. 1 T2-weighted brain MR images on day 1, 14, and 40 after admission. In MR images on day 40, hyperintense foci on T2-weighted images are
unequivocally demonstrated in the bilateral internal capsules (Day 40, a and b) and cerebral white matter near the lateral ventricles (Day 40, c)
Fig. 2 FLAIR MR images of the brain on day 1 and day 40 after admission. The images on day 40 show that hyperintense foci are unequivocally
present in the bilateral internal capsules (Day 40, a, b and d), periependymal regions of the posterior horns of lateral ventricles (Day 40, a, b and d), and
cerebral white matter near the lateral ventricles (Day 40, c)
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associated with poor outcomes, but factors related to
better outcomes are as yet unclear.
We speculated that the second wave of the two-stage
attack in the present patient might have been caused by
an immune-mediated mechanism for the following rea-
sons. The neurological and laboratory findings between
the first and second attacks were quite different. From a
neurological standpoint, the symptoms observed in the
first attack suggested acute transverse myelitis. However,
the second attack was associated with not only a deteri-
oration of the symptoms of transverse myelitis but also
the appearance of new symptoms, including dysarthria,
clumsiness of upper extremities, and truncal ataxia, sug-
gesting that the problem might involve the brain beyond
Fig. 3 T2-weighted MR images of the spinal cord on day 1 and day 26 after admission. On day 26, hyperintense lesions are present at cervical
C2–C6 levels (B, arrows). White matter hyperintensities are also observed on T2-weighted MR images in the posterior portion of the spinal cord (d)
Fig. 4 Time course of clinical symptoms, CSF results, treatment, and MRI findings
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the spinal cord. Regarding the laboratory findings, the
re-elevation of CSF protein was noted during the second
attack, although the extent of the elevation was mild.
However, the MRI findings differed markedly between
the first and second attacks. The appearance of multiple
disseminated white matter lesions with hyperintense
signals in the internal capsules during the second attack
supported the speculation that extensive demyelination
was occurring, as in ADEM. It has been previously
hypothesized that CMV potentially has an antigen-
presentation capacity because the human CMV major
capsid protein shares sequence similarity with an
encephalitogenic myelin/oligodendrocyte glycoprotein
(MOG 34–56) [13].
Recently, Tenenbaum and colleagues proposed that
biphasic disseminated encephalomyelitis (BDEM) is a
variant of ADEM [14]. According to their proposal, pa-
tients manifest a biphasic course, with the second attack
occurring at least 1 month after the initial event showing
different symptoms and radiologic evidence of new le-
sions at a different site. They reported that approxi-
mately 10% of patients with ADEM had the biphasic
disease [14]. The clinical course and neuroimaging find-
ings of the present patient may generally meet the
proposed criteria for BDEM. Indeed, it was reported that
CMV infection is a potential cause of BDEM [15]. How-
ever, there are clear differences in the pathophysiological
mechanisms observed in BDEM and in the present pa-
tient. In BDEM, not only the second but also the first
phase of the illness is caused by ADEM. In the present
patient, as we speculated, the first phase of illness was
caused by direct invasion of CMV. Although it is
possible that the present patient might have BDEM, it is
also plausible that CMV was coincidentally re-activated
during the initial episode of illness.
One additional differential diagnosis that should also
be considered is seronegative neuromyelitis optica
spectrum disorder (NMOSD), because the spinal cord
and the brain were involved in the present patient. In
particular, lesions involving the internal capsule and
periependymal regions of the posterior horns of lateral
ventricles, both of which are known to be typical MRI
neuroimaging of NMOSD, were involved [16]. However,
we think that the present patient may not have NMOSD,
because of the following reasons: 1) anti-AQP-4 IgG was
seronegative; 2) a mildly elevated IgG index also
supports ADEM, because the IgG index value is typically
not elevated in NMOSD; 3) most core clinical features
necessary to fulfill NMOSD were lacking, such as optic
neuritis, area postrema syndrome (hiccup, nausea and
vomiting), narcolepsy or acute diencephalic syndrome,
or acute brainstem syndrome. Additionally, there is a
clear difference in distribution of spinal cord lesions
between NMOSD and the present patient. NMOSD
spinal cord lesions are characterized by exclusive
involvement of gray matter; whereas the present patient
exhibited a lesion in the posterior portion of the spinal
cord. However, although the likelihood that he has
NMOSD is not great, careful follow-up is necessary.
Conclusion
CMV potentially involves the CNS in immunocompetent
patients, possibly through a viral invasion or by post- or
para-infectious immune-mediated demyelination, similar
to what occurs in ADEM. It is clinically important to
recognize that CMV infection may precipitate a two-
stage attack. This case report underscores the import-
ance of careful observation of immunocompetent
patients with CMV, watching out for a secondary attack
by post-infectious ADEM following the initial CMV-
associated inflammation.
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